<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tomiyasu H</submitter><funding>Canon Medical Systems Corporation Tokyo CL Square</funding><funding>Japan Science and Technology Agency Fusion Oriented REsearch for disruptive Science and Technology</funding><funding>Japan Society for the Promotion of Science</funding><pagination>107209</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11021968</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>300(4)</volume><pubmed_abstract>FOXO1 is a transcription factor and potential tumor suppressor that is negatively regulated downstream of PI3K-PKB/AKT signaling. Paradoxically, FOXO also promotes tumor growth, but the detailed mechanisms behind this role of FOXO are not fully understood. In this study, we revealed a molecular cascade by which the Thr24 residue of FOXO1 is phosphorylated by AKT and is dephosphorylated by calcineurin, which is a Ca&lt;sup>2+&lt;/sup>-dependent protein phosphatase. Curiously, single nucleotide somatic mutations of FOXO1 in cancer occur frequently at and near Thr24. Using a calcineurin inhibitor and shRNA directed against calcineurin, we revealed that calcineurin-mediated dephosphorylation of Thr24 regulates FOXO1 protein stability. We also found that FOXO1 binds to the promoter region of MDM2 and</pubmed_abstract><journal>The Journal of biological chemistry</journal><pubmed_title>FOXO1 promotes cancer cell growth through MDM2-mediated p53 degradation.</pubmed_title><pmcid>PMC11021968</pmcid><funding_grant_id>S22-0047</funding_grant_id><funding_grant_id>20K21503</funding_grant_id><funding_grant_id>21H02403</funding_grant_id><funding_grant_id>JPMJFR2065</funding_grant_id><pubmed_authors>Hanaki S</pubmed_authors><pubmed_authors>Tomiyasu H</pubmed_authors><pubmed_authors>Habara M</pubmed_authors><pubmed_authors>Shimada M</pubmed_authors><pubmed_authors>Sato Y</pubmed_authors><pubmed_authors>Miki Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>FOXO1 promotes cancer cell growth through MDM2-mediated p53 degradation.</name><description>FOXO1 is a transcription factor and potential tumor suppressor that is negatively regulated downstream of PI3K-PKB/AKT signaling. Paradoxically, FOXO also promotes tumor growth, but the detailed mechanisms behind this role of FOXO are not fully understood. In this study, we revealed a molecular cascade by which the Thr24 residue of FOXO1 is phosphorylated by AKT and is dephosphorylated by calcineurin, which is a Ca&lt;sup>2+&lt;/sup>-dependent protein phosphatase. Curiously, single nucleotide somatic mutations of FOXO1 in cancer occur frequently at and near Thr24. Using a calcineurin inhibitor and shRNA directed against calcineurin, we revealed that calcineurin-mediated dephosphorylation of Thr24 regulates FOXO1 protein stability. We also found that FOXO1 binds to the promoter region of MDM2 and</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2026-06-01T18:59:36.476Z</modification><creation>2026-05-19T03:07:01.518Z</creation></dates><accession>S-EPMC11021968</accession><cross_references><pubmed>38519029</pubmed><doi>10.1016/j.jbc.2024.107209</doi></cross_references></HashMap>